COchlear
Sparing Therapy And conventional Radiation
A Multicentre Randomised Study Of Cochlear
Sparing Intensity Modulated Radiotherapy Versus Conventional Radiotherapy In
Patients With Parotid Tumours
Objective of the
Study:
To determine in a randomised controlled trial, the potential of
intensity modulated radiotherapy (IMRT) to reduce the incidence of
sensori-neural
hearing loss in patients having radiotherapy to the
parotid region
Contact details for QA
Catharine
Clark
COSTAR Physicist
Department of Physics
020 8661 3698
COSTAR
Pre-trial QA requirements
Details of the QA exercises are provided in the
following document:
Everyone joining COSTAR needs to do the outlining and planning exercises.
If you were a contributor to PARSPORT, CHHiP or IMPORT
High then please contact the QA centre to find out which exercises you do not
need to do.
Outlining
exercise
A COSTAR
case must be delineated according to the trial guidelines and returned to the
QA centre for analysis
- Outlining guidelines
- Outlining
instructions
- Clinical
history
- Outlining CT (Please contact QA centre)
Planning Exercise
A COSTAR
case must be planned both with an IMRT and a conventional plan and returned
electronically to the QA Centre for analysis.
- Instructions for
planning exercise
- Planning guidelines
- COSTAR physics plan assessment form
- Planning CT (Please contact QA centre)
Questionnaires
All three questionnaires
need to be filled in.
- National
Quality Assurance for Clinical trials Baseline questionnaire
- National
Quality Assurance for Clinical trials Staff questionnaire
- COSTAR Trial Physics
Questionnaire. This complements the Baseline Questionnaire, and
provides information on trial-specific items not covered in the Baseline document.
Process document
The
processes document details all aspects of the tasks and time required along the
complete COSTAR patient pathway.
Case reviews
The case
reviews will include a review of the structure outlines and an assessment of
the plan. The first 3 patients will be reviewed, and if these are both in the
same planning group then the next patient from the other planning group will be
reviewed in addition.